^
Association details:
Biomarker:No biomarker
Cancer:Osteosarcoma
Drug:doxorubicin hydrochloride (Topoisomerase II inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
New
Source:
Excerpt:
Doxorubicin Hydrochloride Injection/for Injection is an anthracycline topoisomerase inhibitor indicated…for the treatment of:…metastatic soft tissue sarcoma, metastatic bone sarcomas…